Evidence map›Paper›PMID 19749389›Full record

ReviewThe Netherlands journal of medicine2009

Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?

P P Koopmans, R Ellis, B M Best, S Letendre

Abstract readReview
In one paragraph

Review in The Netherlands journal of medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Update on HIV dementia and HIV-associated neurocognitive disorders.Current neurology and neuroscience reports · 2014
    Review
  4. The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation.The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses · 2013
    Article
  5. Article
  6. Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz.The Journal of pharmacology and experimental therapeutics · 2012
    Article
  7. Article
  8. Article
  9. Assessing and treating forgetfulness and cognitive problems in adults with HIV.The Journal of the Association of Nurses in AIDS Care : JANAC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

P P KoopmansDepartment of General Internal Medicine, Radboud University Medical Center Nijmegen, The Netherlands. p.koopmans@aig.umcn.nl
R Ellis
B M Best
S Letendre

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
Midcareer Investigator Award in Patient-Oriented NeuroAIDS ResearchK24MH097673 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2013 to 2017
$917k
MENTORED INVESTIGATION OF LEVELS OF CSF HIV RNAK23MH001779 · NIMH · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI LETENDRE, SCOTT L · 1999 to 2003
$462k
NIMH NIH HHS K23 MH001779NIMH NIH HHS K24 MH097673NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

The continuous replication of HIV-1 in the central nervous system, in particular the brain, and its potential long-term deleterious effect is the focus of this review. Cognitive deficits are observed in a significant percentage of HIV-1-infected patients. That may occur despite successful peripheral suppression of the HIV-1 replication. Compartmentalisation of HIV-1 in the brain, genetic mutation of HIV-1, age, HCV coinfection and poor intracerebral penetration, as well as possibly a direct toxic effect of antiretroviral drugs, are factors that may account for potential creeping damage of the brain after many years of treatment. Patients with neurological symptoms or cognitive deficits may require another approach to the treatment of their HIV infection.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveBlood-Brain BarrierCognitionCognition DisordersHIV-1HIV InfectionsHumansRisk FactorsAnti-HIV AgentsAnti-Retroviral Agents

Identifiers

PMID19749389
PMCPMC5077299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.